These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 5785442)

  • 21. Transdermal and topical pharmacotherapy for male sexual dysfunction.
    Ohebshalom M; Mulhall JP
    Expert Opin Drug Deliv; 2005 Jan; 2(1):115-20. PubMed ID: 16296739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction.
    Traish AM; Guay A; Feeley R; Saad F
    J Androl; 2009; 30(1):10-22. PubMed ID: 18641413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific aspects of erectile dysfunction in endocrinology.
    Miralles-García JM; García-Díez LC
    Int J Impot Res; 2004 Oct; 16 Suppl 2():S10-2. PubMed ID: 15496851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative characteristics of testosterone preparations for androgen-replacing therapy in male hypogonadism].
    Iudovskiĭ SO; Segal AS; Pushkar' DIu
    Urologiia; 2006; (3):83-4, 86-8. PubMed ID: 16889100
    [No Abstract]   [Full Text] [Related]  

  • 25. [Androgen deficiency and erectile dysfunction].
    Pan LJ; Xia XY; Huang YF
    Zhonghua Nan Ke Xue; 2006 Nov; 12(11):1030-4. PubMed ID: 17146934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy and safety of hormonal therapy with androgens (androgel) in men with erectile dysfunction, partial androgen deficiency of aging male and cardiovascular diseases].
    Kalinchenko SIu; Vorslov LO; Aglamazian NL; Morgunov LIu
    Urologiia; 2007; (1):57, 59-61. PubMed ID: 17472002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of metastasizing breast cancer in general practice].
    Brunner KW
    Schweiz Med Wochenschr; 1973 Oct; 103(41):1406-13. PubMed ID: 4751561
    [No Abstract]   [Full Text] [Related]  

  • 28. Rationale, design and methods of the ESPRIT study: Energy, Sexual desire and body PropoRtions wIth AndroGel, Testosterone 1% gel therapy, in hypogonadal men.
    Behre HM; Heinemann L; Morales A; Pexman-Fieth C
    Aging Male; 2008 Jun; 11(2):101-6. PubMed ID: 18570063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erectile dysfunction in men with HIV-1: effect of hypogonadism and antiretroviral therapy.
    Chan DJ
    J HIV Ther; 2007 Jun; 12(2):54-8. PubMed ID: 17641574
    [No Abstract]   [Full Text] [Related]  

  • 30. Asthma and impotence. The story of an unexpected connection.
    Ollivier JE
    JAAPA; 2000 Jun; 13(6):59-62, 68, 70. PubMed ID: 11503241
    [No Abstract]   [Full Text] [Related]  

  • 31. Men, androgen deficiency, and pharmaceutical promotion.
    Finucane TE
    Arch Intern Med; 2009 Jan; 169(1):88; author reply 88-9. PubMed ID: 19139331
    [No Abstract]   [Full Text] [Related]  

  • 32. [The effects androgen therapy on smoking and non-smoking patients with erectile dysfunction in andropausal syndrome].
    Ludwikowski G; Kazdepka-Ziemińska A; Szymański M; Adamczak R
    Przegl Lek; 2005; 62(10):976-7. PubMed ID: 16521931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The results of clinical studies of the suppression of sexuality by anti-androgens (author's transl)].
    Laschet U; Laschet L
    J Neurovisc Relat; 1971; 0(0):suppl 10:388-93. PubMed ID: 5164902
    [No Abstract]   [Full Text] [Related]  

  • 34. Androgen function after age 50 years and treatment of hypogonadism.
    Korenman SG
    Curr Ther Endocrinol Metab; 1994; 5():585-7. PubMed ID: 7704798
    [No Abstract]   [Full Text] [Related]  

  • 35. Does sildenafil combined with testosterone gel improve erectile dysfunction in hypogonadal men in whom testosterone supplement therapy alone failed?
    Greenstein A; Mabjeesh NJ; Sofer M; Kaver I; Matzkin H; Chen J
    J Urol; 2005 Feb; 173(2):530-2. PubMed ID: 15643239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency.
    Boyanov MA; Boneva Z; Christov VG
    Aging Male; 2003 Mar; 6(1):1-7. PubMed ID: 12809074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. More than eight years' hands-on experience with the novel long-acting parenteral testosterone undecanoate.
    Saad F; Kamischke A; Yassin A; Zitzmann M; Schubert M; Jockenhel F; Behre HM; Gooren L; Nieschlag E
    Asian J Androl; 2007 May; 9(3):291-7. PubMed ID: 17486268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostate cancer following testosterone replacement in Klinefelter syndrome.
    Bydder SA; Joseph DJ; Weinstein S; Stuckey BG
    ANZ J Surg; 2007; 77(1-2):93-4. PubMed ID: 17295832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Androgens in treatment of metastatic breast cancer].
    Horn Y; Horn H; Gordan GS
    Harefuah; 1972 Dec; 83(12):584-5. PubMed ID: 4659031
    [No Abstract]   [Full Text] [Related]  

  • 40. [Mestoranum. What justification has this androgenic steroid?].
    Frey H
    Tidsskr Nor Laegeforen; 1973 May; 93(15):1163-4. PubMed ID: 4751605
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.